EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Melatonin Use in Pediatric Intensive Care Units: A Single-Center Experience

Jessica L Jacobson, Joanna Tylka, Savannah Glazer, Yanyu Zhang, Rosario Cosme, Jean M Silvestri, Pallavi P Patwari iD

Medical Sciences · 2023

DOI: 10.3390/medsci11030055 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Sciences, 2023. Verfasst von Jessica L Jacobson und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Rush University Medical Center (RUMC), Chicago, IL 60612, USA. Hauptthemen laut MEDLINE: Melatonin, Intensive Care Units, Pediatric. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Growing evidence indicates that altered melatonin secretion during critical illness may influence the quality and quantity of sleep, delirium, and overall recovery. However, limited data exist regarding the use of melatonin in pediatric critical illness. Data were reviewed over a 5-year period at a tertiary pediatric intensive care unit for pediatric patients (ages 0–18 years) who were prescribed melatonin with the aim of identifying the frequency of and indications for use. Data collection included the hospital day of initiation, the dose, the frequency, the duration of use, and the length of stay. The results demonstrate that melatonin was infrequently prescribed (6.0% of patients admitted; n = 182) and that the majority of patients received melatonin as continuation of home medication (46%; n = 83 of 182). This group had significantly earlier melatonin use (0.9 ± 2.3 day of hospitalization; p < 0.0001) and significantly reduced lengths of stay compared to the other groups (mean LOS 7.2 ± 9.3 days; p < 0.0001). Frequently, clear documentation of indication for melatonin use was absent (20%; n = 37). In conclusion, given that melatonin is infrequently used within a tertiary PICU with the most common indication as the continuation of home medication, and often without clear documentation for indication, this presents an opportunity to emphasize a more attentive and strategic approach regarding melatonin use in the PICU population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelatoninIntensive Care Units, PediatricHumansChildChild, PreschoolInfantAdolescentMaleFemaleInfant, NewbornLength of StayRetrospective StudiesCritical Illness

Stichwörter der Autor:innen

circadiandeliriuminsomniaintensive caremelatoninpediatricssleep

Substanzen

Melatonin

Autor:innen und Institutionen

  • Department of Pharmacy, Rush University Medical Center (RUMC), Chicago, IL 60612, USA.
  • Department of Pediatrics, RUMC, Rush University Children's Hospital, Chicago, IL 60612, USA.
  • Bioinformatics and Biostatistics Core, RUMC, Chicago, IL 60612, USA.
  • Department of Psychiatry, RUMC, Chicago, IL 60612, USA.

ORCID-Profile: Pallavi P Patwari

Zitieren

APA

Jacobson, J. L., Tylka, J., Glazer, S., Zhang, Y., Cosme, R., Silvestri, J. M., & Patwari, P. P. (2023). Melatonin Use in Pediatric Intensive Care Units: A Single-Center Experience. Medical Sciences. https://doi.org/10.3390/medsci11030055

Vancouver

Jacobson JL, Tylka J, Glazer S, Zhang Y, Cosme R, Silvestri JM, et al. Melatonin Use in Pediatric Intensive Care Units: A Single-Center Experience. Medical Sciences. 2023. doi:10.3390/medsci11030055

BibTeX
@article{Jacobson2023,
  author = {Jacobson, Jessica L and Tylka, Joanna and Glazer, Savannah and Zhang, Yanyu and Cosme, Rosario and Silvestri, Jean M and Patwari, Pallavi P},
  title = {Melatonin Use in Pediatric Intensive Care Units: A Single-Center Experience},
  journal = {Medical Sciences},
  year = {2023},
  doi = {10.3390/medsci11030055}
}
Kostenlos starten →